[http://www.lmsoft.com/] BACKGROUND Dr. Roswitha Gropp, founder and principal of TECHNOLOGY CONSULTING, has over 20 years of experience in research and development. This includes cystic fibrosis, endometriosis, oncology, maturation and transgenic expression of G-protein coupled receptors. In 2000 Dr. Gropp joined the young biotech enterprise Arevia GmbH, Berlin as a scientific consultant and acting CSO. During her time as a lecturer at the University of Frankfurt the CANCER REPORT was initiated. Prior she was scientific group leader at the Gene Therapy Unit, University of Frankfurt, dedicated to the treatment of Cystic Fibrosis. At Parnassus Pharmaceuticals, San Francisco, she gained her first experience in the biotech industry. Supported by a DFG research grant she worked with Herbert Boyer, the founder of Genentech, at the University of San Francisco. Prior she had completed her postdoctoral education at the Max-Planck-Institute of Biochemistry in Munich. Dr. Gropp received her PhD in Biochemistry from the Max-Planck-Institute of Biochemistry in Munich and holds a degree in Chemistry from the University of Würzburg.
TECHNOLOGY CONSULTING Dr. Roswitha Gropp
[./homepag.html]
[./backgroundpag.html]
[./contactpag.html]
[./metabolicspag.html]
[./my_viewpag.html]
[./my_viewpag.html]
[./reportspag.html]
[./cnspag.html]
[./cancer_stem_cellspag.html]
Home Background Reports CANCER CNS METABOLICS CANCER STEM CELLS My View No Magic Bullets Contact